動物幹細胞療法市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競合別、2020～2030年

世界の動物幹細胞療法市場は、2024年に2億3,809万米ドルと評価され、予測期間中に大きな成長を遂げると予測されており、2030年までの年間平均成長率（CAGR）は6.01%です。

この市場は、動物の様々な病状を治療するための幹細胞ベースの治療法に関するものです。この分野は、ペット、家畜、野生動物を含む様々な動物の健康と福祉を向上させる可能性があるため、大きな注目を集めています。

市場促進要因

ペット飼育数の増加と動物ヘルスケア支出の増加

主な市場課題

安全性と有効性への懸念

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物幹細胞療法市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（犬の幹細胞療法、馬の幹細胞療法）
  • 用途別（動物病院、調査機関）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • タイプ別
  • 用途別
  • 地域別

第6章 北米の動物幹細胞療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の動物幹細胞療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域の動物幹細胞療法市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の動物幹細胞療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの動物幹細胞療法市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Ardent Animal Health
• Vet Stem Inc
• Medrego
• Vetbiologics
• VETHERAPY
• Celavie Biosciences
• Magellan Stem Cells
• Animal General
• Animal Cell Therapies, Inc.
• Cell Therapy Sciences Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

The global Animal Stem Cell Therapy Market was valued at USD 238.09 million in 2024 and is projected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 6.01% through 2030. This market pertains to the use of stem cell-based therapies to treat a variety of medical conditions in animals. The sector has attracted considerable attention due to its potential to enhance the health and well-being of various animals, including pets, livestock, and wildlife.

Key Market Drivers

Growth in Pet Ownership and Increased Animal Healthcare Expenditure

The global Animal Stem Cell Therapy Market is benefiting from robust growth driven by rising pet ownership and increased spending on animal healthcare. Over 50% of the global population is estimated to own pets, with households in the U.S., EU, and China collectively hosting more than 500 million dogs and cats. In the U.S., pet ownership has steadily increased, from 68% of households in 2016 to 70% in 2021, reflecting the growing importance of pets in family life. This trend presents substantial opportunities for industries focused on pet care, nutrition, and related services. Consumers are increasingly prioritizing pet-related products and services, particularly in advanced veterinary treatments such as stem cell therapy.

The pet ownership trend continues to rise, especially in developed regions like North America, Europe, and parts of Asia-Pacific. Younger generations, including Millennials and Gen Z, are particularly likely to adopt pets as companions. A survey indicates that 45% of Gen Z and 40% of Millennials consider their pets the most important part of their lives, underlining a significant emotional and financial investment in pet care. In contrast, only 29% of older generations share this perspective, highlighting a generational shift in consumer behavior and spending patterns within the pet care industry.

Additionally, pets are increasingly seen as sources of emotional support, contributing to a growing demand for quality healthcare services. In the Asia-Pacific region, particularly in China, the pet humanization trend is on the rise, with 55% of pet owners considering their pets as children, and 28% regarding them as family members.

Key Market Challenges

Safety and Efficacy Concerns

Ensuring the safety and efficacy of stem cell therapies for animals remains a critical challenge. Although these therapies show significant promise, further research and clinical trials are necessary to establish their long-term safety and effectiveness for various medical conditions across different animal species.

Key Market Players

• Ardent Animal Health
• Vet Stem Inc
• Medrego
• Vetbiologics
• VETHERAPY
• Celavie Biosciences
• Magellan Stem Cells
• Animal General
• Animal Cell Therapies, Inc.
• Cell Therapy Sciences Ltd

Report Scope

This report provides a comprehensive analysis of the global Animal Stem Cell Therapy Market, segmented as follows, with a detailed overview of industry trends:

By Type:

• Dogs Stem Cell Therapy
• Horses Stem Cell Therapy

By Application:

• Veterinary Hospitals
• Research Organizations

By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Competitive Landscape and Company Profiles

The report provides an in-depth analysis of leading companies operating within the global Animal Stem Cell Therapy Market.

Available Customizations

TechSci Research offers customizations tailored to a company's specific needs.

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Stem Cell Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 5.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Type
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Animal Stem Cell Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 6.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Stem Cell Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Animal Stem Cell Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Animal Stem Cell Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Animal Stem Cell Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 7.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Stem Cell Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Animal Stem Cell Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. France Animal Stem Cell Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Animal Stem Cell Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Animal Stem Cell Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Animal Stem Cell Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 8.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Animal Stem Cell Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Animal Stem Cell Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. India Animal Stem Cell Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Animal Stem Cell Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Animal Stem Cell Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Animal Stem Cell Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 9.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Animal Stem Cell Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Animal Stem Cell Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Animal Stem Cell Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Animal Stem Cell Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 10.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Animal Stem Cell Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Animal Stem Cell Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Animal Stem Cell Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
  • 10.3.4. Kuwait Animal Stem Cell Therapy Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Ardent Animal Health
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Vet Stem Inc
• 14.3. Medrego
• 14.4. Vetbiologics
• 14.5. VETHERAPY
• 14.6. Celavie Biosciences
• 14.7. Magellan Stem Cells
• 14.8. Animal General
• 14.9. Animal Cell Therapies, Inc.
• 14.10. Cell Therapy Sciences Ltd

15. Strategic Recommendations

16. About Us & Disclaimer